362 related articles for article (PubMed ID: 29626315)
21. Diabetic Theory in Anti-Alzheimer's Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents.
Jankowska A; Wesołowska A; Pawłowski M; Chłoń-Rzepa G
Curr Med Chem; 2020; 27(39):6658-6681. PubMed ID: 31604406
[TBL] [Abstract][Full Text] [Related]
22. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
23. Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention.
Bachurin SO; Gavrilova SI; Samsonova A; Barreto GE; Aliev G
Pharmacol Res; 2018 Mar; 129():216-226. PubMed ID: 29170097
[TBL] [Abstract][Full Text] [Related]
24. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
25. [Diabetes mellitus and cognitive impairment].
Surkova EV; Tanashyan MM; Bespalov AI; Naminov AV
Ter Arkh; 2019 Oct; 91(10):112-118. PubMed ID: 32598641
[TBL] [Abstract][Full Text] [Related]
26. New Treatment Aimed at Preventing Alzheimer's Dementia.
Kverno K
J Psychosoc Nurs Ment Health Serv; 2022 May; 60(5):11-14. PubMed ID: 35510912
[TBL] [Abstract][Full Text] [Related]
27. Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based study of incidence and risk factors with five years of follow-up.
Ma F; Wu T; Miao R; Xiao YY; Zhang W; Huang G
J Alzheimers Dis; 2015; 43(4):1441-9. PubMed ID: 25159674
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
32. Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents.
Katsel P; Roussos P; Beeri MS; Gama-Sosa MA; Gandy S; Khan S; Haroutunian V
PLoS One; 2018; 13(11):e0206547. PubMed ID: 30383799
[TBL] [Abstract][Full Text] [Related]
33. Diabetes mellitus Type II and cognitive capacity in healthy aging, mild cognitive impairment and Alzheimer's disease.
Degen C; Toro P; Schönknecht P; Sattler C; Schröder J
Psychiatry Res; 2016 Jun; 240():42-46. PubMed ID: 27082868
[TBL] [Abstract][Full Text] [Related]
34. What are we trying to prevent in Alzheimer disease?
Jessen F
Dialogues Clin Neurosci; 2019 Mar; 21(1):27-34. PubMed ID: 31607778
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.
Umegaki H
Drugs Aging; 2016 Jun; 33(6):399-409. PubMed ID: 27138956
[TBL] [Abstract][Full Text] [Related]
36. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
37. Antidiabetic therapies and Alzheimer disease.
Bendlin BB
Dialogues Clin Neurosci; 2019 Mar; 21(1):83-91. PubMed ID: 31607783
[TBL] [Abstract][Full Text] [Related]
38. Intranasal Insulin for Alzheimer's Disease.
Hallschmid M
CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.
Das S; Ramachandran AK; Halder D; Akbar S; Ahmed B; Joseph A
CNS Neurol Disord Drug Targets; 2023; 22(7):973-993. PubMed ID: 35770411
[TBL] [Abstract][Full Text] [Related]
40. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
Li X; Song D; Leng SX
Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
